sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
IRD
Updated 10/6/2026, 12:12 PM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| IRD Opus Genetics, Inc. | Sale | $2,755,981 | Foundation Fighting Blindness Retinal Degeneration Fund Director and 1 other | 556,000 sh | at $4.96 | Filed Oct 2, 7:47 PM ET | Filing | |
| IRD Opus Genetics, Inc. | Sale | $127,212 | Gagnon Robert E. Chief Financial Officer | 28,000 sh | at $4.54 | Filed Sep 8, 4:05 PM ET | Filing | |
| IRD Opus Genetics, Inc. | Sale | $22,064 | YERXA BENJAMIN R President, Director | 7,429 sh | at $2.97 | Filed Jul 27, 4:08 PM ET | Filing | |
| IRD Opus Genetics, Inc. | Sale | $13,653 | SCHACHLE JOSEPH K Chief Operating Officer | 4,644 sh | at $2.94 | Filed Jul 27, 4:07 PM ET | Filing | |
| IRD Opus Genetics, Inc. | Sale | $27,926 | Magrath George Chief Executive Officer, Director | 9,475 sh | at $2.95 | Filed Jul 27, 4:07 PM ET | Filing | |
| IRD Opus Genetics, Inc. | Sale | $22,942 | Gagnon Robert E. Chief Financial Officer | 7,783 sh | at $2.95 | Filed Jul 27, 4:06 PM ET | Filing |